Cargando…
RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
Autores principales: | Zhou, Shiwei, Obianom, Obinna N., Huang, Jiangsheng, Guo, Dong, Yang, Hong, Li, Qing, Shu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301172/ https://www.ncbi.nlm.nih.gov/pubmed/37376227 http://dx.doi.org/10.3390/pharmaceutics15061623 |
Ejemplares similares
-
Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-catenin Downregulation and AMPK Activation
por: Zhou, Shiwei, et al.
Publicado: (2021) -
Retraction: miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5
Publicado: (2021) -
Circular RNA Circ_0025033 Promotes the Evolvement of Ovarian Cancer Through the Regulation of miR-330-5p/KLK4 Axis [Retraction]
Publicado: (2021) -
Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9
por: Zhang, Zi-Feng, et al.
Publicado: (2022) -
Retraction: Central Exercise Action Increases the AMPK and mTOR Response to Leptin
Publicado: (2018)